- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02909881
Dose Response Oxidation of a Sweet-corn Derived Sugar (PhytoSpherix) During Exercise in Endurance Trained Athletes
September 21, 2016 updated by: Peter Lemon, University of Western Ontario, Canada
Dose Response Oxidation of a Sweet-corn Derived Polysaccharide (PhytoSpherix) During Exercise in Endurance Trained Athletes
PhytoSpherix (Phx) is an all-natural, edible polysaccharide extracted from sweet corn.
This carbohydrate is the major muscle fuel for intense exercise and its stores are quite small such that one can run out of it during a single exercise bout.
Therefore, Phx should provide significant exercise fuel if consumed during exercise.
As a result its intake could enhance intense exercise performance by providing additional fuel.
This experiment Will investigate the effects of 4 different dosages of Phx consumed throughout a prolonged exercise bout on carbohydrate and fat utilization as well as its oxidation rate and perception of effort during prolonged intense exercise in trained cyclists.
Muscle and liver carbohydrate stores will be examined using a non-invasive ultrasound technique.
Study Overview
Status
Unknown
Conditions
Detailed Description
Carbohydrate (CHO) is one of the main substrate oxidized during moderate-to-high intensity, endurance-type exercise.
It's been shown that CHO feeding during exercise enhances endurance performance and capacity, attributed mainly to the facilitation of greater rates of exogenous CHO oxidation, prevention of hypoglycaemia and sparing of muscle glycogen.
Previous studies based on supplementation of glucose during 180 min. of cycling exercise have reported a maximal rate of exogenous CHO oxidation to be about 1 g/min.
Other studies have shown that CHO oxidation rates can reach peak values of about 1.3 g/min when a combination of fructose and glucose is ingested at a rate of 1.8 g/min.
The limitation in uptake and oxidation of a single CHO source is attributed to its intestinal transporter saturation such that when multiple CHO source is used the uptake and oxidation rate is increased to a greater extent.
Currently there is no information regarding Phx uptake or oxidation rate as a CHO source during exercise.
Also, it is important to investigate whether Phx as a CHO sport drink can increase performance by sparing muscle and liver glycogen during exercise.
Therefore, the objective of this experiment is to measure dose response of Phx oxidation rate during prolonged cycling exercise and its effect on muscle and liver glycogen levels.
Study Type
Interventional
Enrollment (Anticipated)
8
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
London, Ontario, Canada, N6A 3K7
- Exercise Nutrition Research Laboratory, Western University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 30 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Healthy male endurance trained athletes with >2 y cycling experience; about 2 h/day
Exclusion Criteria:
- Unhealthy athletes, smokers
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Endurance trained male cyclists
8 male endurance trained male cyclist will consume varying amounts (0, 1, 1.5 and 2 g/min) of PhytoSpherix (sweet-corn derived sugar) during a 150 min .
cycling exercise
|
PhytoSpherix (Sweet-corn derived sugar) will be fed at 0 g/min during a 150 min cycling exercise
PhytoSpherix (Sweet-corn derived sugar) will be fed at 1 g/min during a 150 min cycling exercise
PhytoSpherix (Sweet-corn derived sugar) will be fed at 1.5 g/min during a 150 min cycling exercise
PhytoSpherix (Sweet-corn derived sugar) will be fed at 2 g/min during a 150 min cycling exercise
Male endurance athletes will complete a cycling exercise for 150 min at 50% of their respective maximum wattage
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oxidation of PhytoSpherixat
Time Frame: 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session
|
Breath samples will be taken starting at 0, 15, 30, 45, 60, 75, 90, 135, up to 150 min from the beginning of the exercise session to measure change in oxidation of PhytoSpherix
|
0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session
|
|
Noninvasive ultrasound measure of glycogen in Vastus lateralis, rectus femoris and liver
Time Frame: 10 min before and 10 min after the 150 min exercise session
|
Change in muscle and liver glycogen will be measured 10 min before and 10 min after exercise session.
When muscle and liver glycogen content is high, the ultrasound image is hypoechoic (dark), and with glycogen depletion and water loss, the image is hyperchoic (brighter).Three ultrasound measurements at each site will be made by a trained technician using a 12 MHz linear transducer and a standard diagnostic high resolution GE LOGIQ-e ultrasound machine (GE Healthcare, Milwaukee, WI).
After calculating statistics on the color bar to determine the general brightness settings of the machine, images will be pre-processed and segmented to isolate the muscle area under analysis using a center crop within the muscle section 25 mm from the top muscle sheath.
Comparing these results will help better understand the effect of supplementation of Phx at different rates on any changes in glycogen stores of muscle and liver.
|
10 min before and 10 min after the 150 min exercise session
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
blood glucose concentration
Time Frame: 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session
|
Changes in blood glucose will be measured at 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session.
A blood drop by finger prick approach starting at time 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session under sterile practice will be used to determine blood glucose concentrations
|
0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session
|
|
blood lactate concentration
Time Frame: 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session
|
Changes in blood lactate will be measured at 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session.
A blood drop by finger prick approach starting at time 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session under sterile practice will be used to determine blood lactate concentrations
|
0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session
|
|
Respiratory exchange ratio
Time Frame: At 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session
|
Respiratory exchange ratio will be measured at 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session for periods of 4 min by using an online automated gas-analysis system.
|
At 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session
|
|
rate of perceived exertion
Time Frame: At 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session
|
rate of perceived exertion (RPE) for whole body and legs will be measured at 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session on a scale from 6 to 20, using the Borg category scale.
|
At 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session
|
|
questionnaire to rate possible gastrointestinal (GI) problems
Time Frame: At 30, 60, 90, 120 and 150 min from the beginning of the exercise session
|
every athlete will be asked at 30, 60, 90, 120 and 150 min from the beginning of the exercise session to fill in a questionnaire to rate possible gastrointestinal (GI) problems including stomach problems, GI cramping, bloated feeling, diarrhea, nausea, dizziness, headache, belching, vomiting, and urge to urinate and defecate.
While cyclists are on the bike and continue their exercise, each question will be answered by simply ticking a box on the questionnaire that corresponds to the severity of the GI problem addressed.
The items will be scored on a 10-point scale (1 not at all, 10 very, very much).
|
At 30, 60, 90, 120 and 150 min from the beginning of the exercise session
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2016
Primary Completion (Anticipated)
September 1, 2017
Study Completion (Anticipated)
September 1, 2017
Study Registration Dates
First Submitted
September 10, 2016
First Submitted That Met QC Criteria
September 17, 2016
First Posted (Estimate)
September 21, 2016
Study Record Updates
Last Update Posted (Estimate)
September 22, 2016
Last Update Submitted That Met QC Criteria
September 21, 2016
Last Verified
September 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10014597
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.